EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Prognostic Impact of Heart Failure Admission in Survivors of Acute Myocardial Infarction

Satoshi Takeuchi iD, Satoshi Honda, Kensaku Nishihira, Sunao Kojima, Misa Takegami, Yasuhide Asaumi, Mike Saji, Jun Yamashita, Kiyoshi Hibi, Jun Takahashi, Yasuhiko Sakata, Morimasa Takayama und 5 weitere

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.14790 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Satoshi Takeuchi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Tohoku University, Sendai, Japan. Hauptthemen laut MEDLINE: Heart Failure, Myocardial Infarction, Registries. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Daiichi-Sankyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The incidence and prognosis of symptomatic heart failure following acute myocardial infarction (AMI) in the primary percutaneous coronary intervention era have rarely been reported in the literature. This study aimed to (i) determine the incidence of heart failure admission among AMI survivors, (ii) compare 1 year outcomes between patients with heart failure admission and those without, and (iii) identify the independent risk factors associated with heart failure admission. Methods and results The Japan Acute Myocardial Infarction Registry is a prospective multicentre registry from which data on consecutively enrolled patients with AMI from 50 institutions between 2015 and 2017 were obtained. Among the 3411 patients enrolled, 3226 who survived until discharge were included in this study. The primary endpoint was all-cause mortality. The secondary endpoints were major adverse cardiovascular events (defined as cardiovascular mortality, non-fatal myocardial infarction, or non-fatal cerebral infarction) and major bleeding events corresponding to Bleeding Academic Research Consortium Type 3 or 5. Clinical outcomes were compared between the patients who were and were not admitted for heart failure. Over a median follow-up of 12 months, 124 patients (3.8%) were admitted due to heart failure. Independent risk factors for heart failure admission included older age, female sex, Killip class ≥2 on admission, left ventricular ejection fraction <40%, estimated glomerular filtration rate ≤30 mL/min/1.73 m2, a history of malignancy, and non-use of angiotensin-converting enzyme inhibitors at discharge. The cumulative incidence of all-cause mortality was significantly higher in the heart failure admission group than in the no heart failure admission group (11.3% vs. 2.5%, P < 0.001). The rates of major adverse cardiovascular events (16.9% vs. 2.7%, P < 0.001) and major bleeding (6.5% vs. 1.6%, P < 0.001) were significantly higher in the heart failure admission group. Heart failure admission was associated with a higher risk of all-cause mortality, even after adjusting for potential confounders (adjusted hazard ratio: 2.41, 95% confidence interval: 1.33–4.39, P = 0.004).

Conclusions

Utilizing real-world data of the contemporary percutaneous coronary intervention era from the Japan Acute Myocardial Infarction Registry database, this study demonstrates that the heart failure admission of AMI survivors was significantly associated with higher all-cause mortality rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMyocardial InfarctionRegistriesHumansMaleFemaleAgedPrognosisJapanProspective StudiesIncidenceFollow-Up StudiesRisk FactorsMiddle AgedSurvival RateHospitalizationCause of DeathPercutaneous Coronary InterventionSurvivors

Stichwörter der Autor:innen

Acute myocardial infarctionHeart failurePercutaneous coronary interventionRegistry

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Tohoku University, Sendai, Japan.
  • Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Centre, Suita, Japan.
  • Department of Cardiovascular Medicine, Miyazaki Medical Association Hospital, Miyazaki, Japan.
  • Department of Internal Medicine, Sakurajyuji Yatsushiro Rehabilitation Hospital, Yatsushiro, Japan.
  • Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Centre, Suita, Japan.
  • Department of Public Health and Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Satoshi Takeuchi

Förderung

  • Daiichi-Sankyo

Zitieren

APA

Takeuchi, S., Honda, S., Nishihira, K., Kojima, S., Takegami, M., Asaumi, Y., Saji, M., Yamashita, J., Hibi, K., Takahashi, J., Sakata, Y., Takayama, M., Sumiyoshi, T., Ogawa, H., Kimura, K., Yasuda, S., & JAMIR Investigators (2024). Prognostic Impact of Heart Failure Admission in Survivors of Acute Myocardial Infarction. ESC Heart Failure. https://doi.org/10.1002/ehf2.14790

Vancouver

Takeuchi S, Honda S, Nishihira K, Kojima S, Takegami M, Asaumi Y, et al. Prognostic Impact of Heart Failure Admission in Survivors of Acute Myocardial Infarction. ESC Heart Failure. 2024. doi:10.1002/ehf2.14790

BibTeX
@article{Takeuchi2024,
  author = {Takeuchi, Satoshi and Honda, Satoshi and Nishihira, Kensaku and Kojima, Sunao and Takegami, Misa and Asaumi, Yasuhide and Saji, Mike and Yamashita, Jun and Hibi, Kiyoshi and Takahashi, Jun and Sakata, Yasuhiko and Takayama, Morimasa and Sumiyoshi, Tetsuya and Ogawa, Hisao and Kimura, Kazuo and Yasuda, Satoshi and JAMIR Investigators, JAMIR Investigators},
  title = {Prognostic Impact of Heart Failure Admission in Survivors of Acute Myocardial Infarction},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.14790}
}
Kostenlos starten →